image
Soleno Therapeutics, Inc. SLNO
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 51.8
-4.22 %
$ 2.23 B
Market Cap
-18.57
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-41.4 M OPERATING INCOME
-69.63%
Growth Rates
1Year -69.63%
3Years -4.48%
5Years -23.68%
7Years -17.22%
10Years -47.54%
-39 M NET INCOME
-62.00%
Growth Rates
1Year -62.00%
3Years -16.53%
5Years -26.91%
7Years -18.24%
10Years -26.53%
EFFICIENCY
Earnings Waterfall Soleno Therapeutics, Inc.
image
Revenue 0
Cost Of Revenue 1.96 M
Gross Profit -1.96 M
Operating Expenses 41.4 M
Operating Income -41.4 M
Other Expenses -2.4 M
Net Income -39 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0 0 0 0 0 0 (1 553.0) 1.5 0.4 0 3.0 0
GROSS PROFIT
Cost Of Revenue 2.0 2.2 2.2 2.2 2.3 1.9 1.6 1.5 0.4 0 0 0
Gross Profit (2.0) (2.2) (2.2) (2.2) (2.3) (1.9) (1 554.6) 58.5 K 34.9 K 0 3.0 0
OPERATING INCOME
Operating Expenses 41.4 25.1 32.3 31.9 23.2 13.7 9.7 13.6 12.2 5.2 3.8 3.6
Selling, General and Administrative Expenses 13.5 9.8 10.8 8.8 6.9 6.6 6.6 8.4 7.9 2.9 1.5 1.1
Research and Development Expenses 25.2 15.3 21.5 23.2 16.3 7.2 3.1 5.2 4.5 2.2 2.4 2.5
Operating Income (41.4) (24.4) (31.5) (36.3) (23.5) (14.3) (12.2) (13.6) (12.2) (5.2) (0.8) (3.6)
PRE-TAX INCOME
Interest Income Expense 0 (0.3) 0 0 0 62 K 0 0 0 4.1 2.9 2.9
Total Other Income 2.4 0.3 0.6 11.7 (7.3) 2.5 (1.3) 1.6 (3.7) (8.1) (2.9) (2.9)
Pre-Tax Income (39.0) (24.1) (30.9) (24.6) (30.8) (11.8) (13.7) (12.0) (15.9) (13.9) (3.7) (6.5)
NET INCOME
Tax Provision 0 (3.7) (1.3) (9.3) 5.1 2.5 (1.7) 21.7 K (0.2) (0.5) 2.9 2.8
Net Income (39.0) (20.3) (29.6) (15.4) (35.9) (13.3) (15.7) (12.1) (15.9) (13.9) (3.7) (6.5)
EPS 2.36 2.42 5.56 3.68 15.8 9.54 26.2 58.4 127 819 198 347